Gail Naughton, Director at CR Bard, holds 0.00 shares in TherapeuticsMD (Ticker: TXMD), holds 426.53K shares in Histogen (Ticker: HSTO), holds 0.00 shares in CR Bard (Ticker: BCR). Most recently, Gail Naughton Sold ― shares of TherapeuticsMD on Dec 08, 2022 for an estimated value of 20.63K.
Gail Naughton latest transaction was an Informative Sell of $20.63K.
What was Gail Naughton's most profitable transaction?
Gail Naughton’s most profitable transaction was an Informative Sell of TXMD stock on December 8, 2022. The return on the trade was 65.20%.
What is Gail Naughton's role in CR Bard?
Gail Naughton's role in CR Bard is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.